1h Free Analyst Time
The female contraceptive market is forecasted to grow byUSD 4.57 billion during 2023-2028, accelerating at a CAGR of 4.6% during the forecast period. The report on the female contraceptive market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing adoption of innovative marketing strategies, evolving consumer perspective, and availability of different methods of contraception.
The female contraceptive market is segmented as below:
By Distribution Channel
- Offline
- Online
By Product
- Female contraceptive devices
- Female contraceptive drugs
By Geography
- North America
- Europe
- APAC
- South America
- Middle East and Africa
The report on the female contraceptive market covers the following areas:
- Female contraceptive market sizing
- Female contraceptive market forecast
- Female contraceptive market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Distribution Channel
7 Market Segmentation by Product
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global female contraceptive market: AbbVie Inc., Afaxys Pharma LLC, Agile Therapeutics Inc., Amgen Inc., Ansell Ltd., Bayer AG, The Cooper Companies Inc., Cupid Ltd., Exeltis USA Inc., Johnson and Johnson Services Inc., Mayer Laboratories Inc., Medisafe Distribution Inc., Merck and Co. Inc., Pfizer Inc., Piramal Enterprises Ltd., Reckitt Benckiser Group Plc, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Veru Inc., and Viatris Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increasing popularity of female condoms."
According to the report, one of the major drivers for this market is the increasing adoption of innovative marketing strategies.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Inc.
- Afaxys Pharma LLC
- Agile Therapeutics Inc.
- Amgen Inc.
- Ansell Ltd.
- Bayer AG
- The Cooper Companies Inc.
- Cupid Ltd.
- Exeltis USA Inc.
- Johnson and Johnson Services Inc.
- Mayer Laboratories Inc.
- Medisafe Distribution Inc.
- Merck and Co. Inc.
- Pfizer Inc.
- Piramal Enterprises Ltd.
- Reckitt Benckiser Group Plc
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- Veru Inc.
- Viatris Inc.
